HIV Infection–Associated Tuberculosis: The Epidemiology and the Response

Cited by (596)

Items 101–200 of 596

1. Investigation of mathematical model of transmission co-infection TB in HIV community with a non-singular kernel
   Lei Zhang, Mati ur Rahman, Muhammad Arfan, Amir Ali · 2021 · Results in Physics
2. Coinfections in Tuberculosis in Low- and Middle-Income Countries: Epidemiology, Clinical Implications, Diagnostic Challenges, and Management Strategies—A Narrative Review
   Ramona Cioboată, Mara Amalia Bălteanu, Andrei Osman, Silviu Gabriel Vlăsceanu, Ovidiu Mircea Zlatian, Denisa Maria Mitroi, Oana Maria Catană, Adriana Socaci, Eugen Nicolae Țieranu · 2025 · Journal of Clinical Medicine
3. Predictors of Tuberculosis and Human Immunodeficiency Virus Co-infection: A Case-Control Study
   Leila Molaeipoor, Jalal Poorolajal, Minoo Mohraz, Nader Esmailnasab · 2014 · Epidemiology and Health
4. Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South Africa
   Carrie Tudor, Martie L. Van der Walt, Bruce Margot, Susan E. Dorman, William Pan, Gayane Yenokyan, Jason E. Farley · 2016 · Clinical Infectious Diseases
5. Predictors of Bovine TB Risk Behaviour amongst Meat Handlers in Nigeria: A Cross-Sectional Study Guided by the Health Belief Model
   Dupe Arinola Hambolu, Jenny V Freeman, Henock B. Taddese · 2013 · PLoS ONE
6. Prisoners co‐infected with tuberculosis and HIV: a systematic review
   Chantal Edge, Emma King, Kate A Dolan, Martin McKee · 2016 · Journal of the International AIDS Society
7. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries
   José Cadena, Selvalakshmi Rathinavelu, Juan Carlos López-Alvarenga, Blanca I. Restrepo · 2019 · Tuberculosis
8. Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria
   Baba Maiyaki Musa, Baba Maiyaki Musa, Hamza Muhammed, İbrahim Nashabaru, Musa Abubakar Garbati · 2015 · Annals of Thoracic Medicine
9. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults
   Di Sun, Susan E. Dorman, Maunank Shah, Yukari Carol Manabe, Vineshree Mischka Moodley, Mark Patrick Nicol, David W. Dowdy · 2013 · The International Journal of Tuberculosis and Lung Disease
10. High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study
    Megbaru Alemu, Gashaw Andargie, Ejigu Gebeye · 2016 · PLoS ONE
11. Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
    Kathryn Anne Lurain, Ramya Ramaswami, Robert Yarchoan, Thomas S. Uldrick · 2020 · Current HIV/AIDS Reports
12. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective
    Todia Pediatama Setiabudiawan, Remi K. Reurink, Philip C. Hill, Mihai Gheorghe Netea, Reinout van Crevel, Valerie A. C. M. Koeken · 2021 · Med
13. Investigation of the risk factors for pulmonary tuberculosis
    Jyothi Bhat, Vikas Gangadhar Rao, RAVENDRA KUMAR SHARMA, Malaisamy Muniyandi, Rajiv Yadav, MK Bhondley · 2017 · The Indian Journal of Medical Research
14. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
    Charlotte Ajeong Chang, Seema Meloni, Geoffrey Eisen, Beth Chaplin, Patrick Aboh Akande, Prosper Okonkwo, Holly E. Rawizza, Eric Tchetgen Tchetgen, Phyllis J. Kanki · 2015 · Open Forum Infectious Diseases
15. Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx
    Tae Gun Kang, Kee Woong Kwon, Kyung Soo Kim, Insuk Lee, Myeong Joon Kim, Sang‐Jun Ha, Sung Jae Shin · 2022 · Nature Communications
16. Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
    Damani A. Piggott, Petros C. Karakousis · 2010 · Clinical and Developmental Immunology
17. Respiratory diseases in the world. Realities of today - opportunities for tomorrow
    Darcy D. Marciniuk · 2014
18. Incidence and Predictors of Tuberculosis among HIV/AIDS Infected Patients: A Five-Year Retrospective Follow-Up Study
    Mulugeta Dalbo, Alemu Tamiso · 2016 · Advances in Infectious Diseases
19. Modeling the Dynamic Relationship Between HIV and the Risk of Drug-Resistant Tuberculosis
    Rinat Sergeev, Caroline Colijn, Megan B. Murray, Ted Cohen · 2012 · Science Translational Medicine
20. Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
    Lukas Fenner, Mathieu Forster, Andrew Boulle, Sam Phiri, Paula K. A. Braitstein, Charlotte Lewden, Mauro Schechter, N. Kumarasamy, Margaret J. Pascoe, Eduardo Sprinz et al. · 2011 · The International Journal of Tuberculosis and Lung Disease
21. HIV TB coinfection - perspectives from India
    Bharat Bhushan Rewari, Amitabh Kumar, Partha Pratim Mandal, Anoop Kumar Puri · 2021 · Expert Review of Respiratory Medicine
22. Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
    Shaheer Ahmad, Debapriya Bhattacharya, Santosh Kumar Kar, Anand Ranganathan, Luc Van Kaer, Gobardhan Das · 2019 · Infection and Immunity
23. Treatment outcome of tuberculosis patients at National Hospital Abuja Nigeria: a five year retrospective study
    Onyebuchi Stephanie Ofoegbu, Bethrand Brian Odume · 2015 · South African Family Practice
24. Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens
    Ning Tang, Andrea Frank, Vihanga Pahalawatta, John Lampinen, Anke Coblenz-Korte, Chad Dunn, Cheng Li, Gavin Cloherty, Klara Abravaya, Gregor W. Leckie · 2015 · Tuberculosis
25. HIV and multidrug-resistant tuberculosis: overlapping epidemics
    Anna S Dean, Matteo Zignol E, Dennis Falzon, Haileyesus Getahun, Katherine Floyd · 2014 · European Respiratory Journal
26. Self-reported adherence and associated factors to isoniazid preventive therapy for latent tuberculosis among people living with HIV/AIDS at health centers in Gondar town, North West Ethiopia
    Asnakew Achaw Ayele, Seyfe Asrade Atnafie, Demis Diriba Balcha, Asegedech Tsegaw Weredekal, Birhanu Alemayehu Woldegiorgis, Mulgeta Melaku Wotte, Begashaw Melaku Gebresillassie · 2017 · Patient Preference and Adherence
27. Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population
    Dhêmerson Souza de Lima, Maurício Morishi Ogusku, Maisa Porto dos Santos, Cláudia Maria de Melo Silva, Vanessa Alves de Almeida, Irineide Assumpção Antunes, Antônio Luiz Boechat, Rajendranath Ramasawmy, Aya Sadahiro · 2016 · PLoS ONE
28. The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control
    Akaninyene Otu, Madiha Hashmi, Ahmed Mohammed Mukhtar, Arthur Kwizera, Simon Tiberi, Bruce Macrae, Alimuddin I. Zumla, Martin W. Dünser, Mervyn Mer · 2018 · Journal of Critical Care
29. The re-emergency and persistence of vaccine preventable diseases
    Rodrigo Borba, Vinícius Mendes Vidal, Lílian Oliveira Moreira · 2015 · Anais da Academia Brasileira de Ciências
30. Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis–Specific T-Cell Responses
    Lyle Murray, Iman Satti, Jodi Meyerowitz, Matthew Jones, Christian B. Willberg, James E. Ussher, Dominique Goedhals, Jacob M. Hurst, Rodney E. Phillips, Helen McShane et al. · 2018 · The Journal of Infectious Diseases
31. Nanowire Aptasensors for Electrochemical Detection of Cell-Secreted Cytokines
    Ying Liu, Ali Rahimian, Sergiy G. Krylyuk, Tam Vu, Bruno Pereira Crulhas, Gulnaz Stybayeva, Meruyert Imanbekova, Dong‐Sik Shin, Albert V. Davydov, Alexander Revzin · 2017 · ACS Sensors
32. TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study
    Gail Brenda Cross, Katie A. Coles, Mandana Nikpour, Owen A. Moore, Justin Timothy Denholm, Emma Sue McBryde, Damon P. Eisen, Beverlyn Warigi, Robyn Carter, Sushil Kumar Pandey et al. · 2014 · BMC Infectious Diseases
33. The Extended Impact of Human Immunodeficiency Virus/AIDS Research
    Tara A. Schwetz, Anthony S. Fauci · 2018 · The Journal of Infectious Diseases
34. Multifaceted Impact of Host C–C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection
    Abdul Wahid Ansari, Adeeba Kamarulzaman, Reinhold Ernst Schmidt · 2013 · Frontiers in Immunology
35. Current and novel approaches to vaccine development against tuberculosis
    M. Cayabyab, L. Macovei, A. Campos-Neto · 2012 · Front. Cell. Inf. Microbio.
36. The Natural Killer Cell Interferon-Gamma Response to Bacteria Is Diminished in Untreated HIV-1 Infection and Defects Persist Despite Viral Suppression
    Stephanie M. Dillon, Eric J. Lee, Julia M. Bramante, Edward Barker, Cara C. Wilson · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
37. The Microbe, the Infection Enigma, and the Host
    Jean‐Laurent Casanova, Laurent Abel · 2024 · Annual Review of Microbiology
38. The prevalence of HIV among adults with pulmonary TB at a population level in Zambia
    Pascalina Chanda‐Kapata, Nathan Kapata, Eveline Klinkenberg, Martin P. Grobusch, Frank G. J. Cobelens · 2017 · BMC Infectious Diseases
39. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment
    Robert Douglas Bruce, Barrot H. Lambdin, Olivia Chang, Frank Masao, Jessie Kazeni Kilonzo Mbwambo, Ibrahim Mteza, Cassian Nyandindi, Sophia Zamudio‐Haas, Deus C. Buma, Megan S. Dunbar et al. · 2013 · International Journal of Drug Policy
40. Abnormal Tryptophan Metabolism in HIV and Mycobacterium tuberculosis Infection
    Xiaolei Wang, Smriti Mehra, Deepak Kaushal, Ronald S. Veazey, Huanbin Xu · 2021 · Frontiers in Microbiology
41. Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT
    Yiyan Liu · 2011 · Annals of Nuclear Medicine
42. Protein Phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection
    Jim Sun, Kaitlyn Schaaf, Alexandra Emilie Duverger, Frank Wolschendorf, Alexander Speer, Frederic Wagner, Michael Niederweis, Olaf Kutsch · 2016 · Oncotarget
43. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya
    Philip Owiti, Dickens Onyango, Robina Kerubo Momanyi, Anthony David Harries · 2019 · BMC Public Health
44. Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
    Daniel Gebretsadik, Nuru Ahmed, Edosa Kebede, Miftah Mohammed, Melaku Ashagrie Belete · 2020 · Infection and Drug Resistance
45. Epidemiology of Tuberculosis Immunology
    Gregory James Fox, Dick Menzies · 2013 · Advances in experimental medicine and biology
46. Patient non adherence to tuberculosis treatment in Sudan: socio demographic factors influencing non adherence to tuberculosis therapy in Khartoum State
    Ahmed Osman Ahmed, Martinus Hendrik Prins · 2016 · Pan African Medical Journal
47. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study
    Amenu Wesen Denegetu, Bethabile Lovely Dolamo · 2014 · BMC Public Health
48. How can mathematical models advance tuberculosis control in high HIV prevalence settings?
    Rein M G J Houben, David W. Dowdy, Anna Vassall, Ted Cohen, Mark Patrick Nicol, Reuben Granich, J. E. Shea, Philip A. Eckhoff, Christopher Dye, Michael E. Kimerling et al. · 2014 · The International Journal of Tuberculosis and Lung Disease
49. In vitro antimicrobial activity of traditional plant used in mestizo shamanism from the Peruvian amazon in case of infectious diseases
    Vincent Roumy, Andréa-Luz Gutierrez-Choquevilca, Jeshus Jean Pierre López Mesía, Lastenia Ruiz Mesía, Juan Celidonio Ruiz Macedo, Amin Abedini, Ameni Landoulsi, Jennifer Samaillie, Thierry Hennebelle, Céline Rivière et al. · 2015 · Pharmacognosy Magazine
50. Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
    Sepiso Kenias Masenga, Harrison Mubila, Benson M. Hamooya · 2017 · BMC Infectious Diseases
51. Recent advances for identification of new scaffolds and drug targets for Mycobacterium tuberculosis
    Rohan Dhiman, Ramandeep Singh · 2018 · IUBMB Life
52. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India
    Gerardo Alvarez‐Uria, Raghavakalyan Pakam, Manoranjan Midde, Praveen Kumar Naik · 2014 · Journal of the International AIDS Society
53. The Role of Dendritic Cells in TB and HIV Infection
    Rachel Abrahem, Emerald Chiang, Joseph Haquang, Amy Nham, Yu-Sam Ting, Vishwanath Venketaraman · 2020 · Journal of Clinical Medicine
54. Diabetes and Tuberculosis
    Blanca I. Restrepo · 2018 · Springer eBooks
55. Comparative pharmacokinetic evaluation of lopinavir and lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model
    Punna Rao Ravi, Rahul Vats · 2017 · Journal of Pharmacy and Pharmacology
56. Diabetes and Tuberculosis
    Blanca I. Restrepo · 2017 · ASM Press eBooks
57. Rapid Diagnosis of Tb Using GC–MS and Chemometrics
    Ngoc A. Dang, Hans‐Gerd Janssen, Arend H. J. Kolk · 2013 · Bioanalysis
58. The association between chronic kidney disease and tuberculosis; a comparative cohort study in England
    Judith Ruzangi, Masao Iwagami, Liam L Smeeth, Punam Mangtani, Dorothea Nitsch · 2020 · BMC Nephrology
59. Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy
    Abraham Mosigisi Siika, Constantin Theodore Yiannoutsos, Kara Wools‐Kaloustian, Beverly Sue Musick, Ann Mwangi, Lameck Oteko Diero, Sylvester N. Kimaiyo, William M. Tierney, Jane E. Carter · 2013 · PLoS ONE
60. Tuberculosis Treatment Outcomes and Determinants among Patients Treated in Hospitals in Imo State, Nigeria
    Chukwuma B. Duru, Kenechi Uwakwe, Chinomnso Chinanuekpere Nnebue, Kelvin C. Diwe, Irene A. Merenu, Chima A. Emerole, Anthony C. Iwu, Chioma A. Duru · 2016 · OALib
61. Low Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability
    Leslie Chávez‐Galán, Dominique Vesin, Denis Martinvalet, Irène Garcia · 2016 · Journal of Immunology Research
62. HIV-TB Coinfection among 57 Million Pregnant Women, Obstetric Complications, Alcohol Use, Drug Abuse, and Depression
    Dorian Fernandez, Imoleayo Salami, Janelle Davis, Florence Mbah, Aisha O. Kazeem, Abreah Ash, Justin Babino, Laquiesha Carter, Jason L. Salemi, Kiara K. Spooner et al. · 2018 · Journal of Pregnancy
63. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study
    Agazhe Aemro, Abebaw Jember Ferede, Degefaye Zelalem Anlay · 2020 · BMC Infectious Diseases
64. First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
    Bijaya Malla, David Stucki, Sònia Borrell, Julia Feldmann, Bhagwan Maharjan, Bhawana Shrestha, Lukas Fenner, Sébastien Gagneux · 2012 · PLoS ONE
65. Workplace programmes for HIV and tuberculosis: A systematic review to support development of international guidelines for the health workforce
    Annalee Yassi, Lyndsay M. O’Hara, Karen Lockhart, Jerry Spiegel · 2012 · AIDS Care
66. MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection
    Sarah A.E. Rupprechter, Derek James Sloan, Wilna Oosthuyzen, Till T. Bachmann, Adam T. Hill, Kevin Dhaliwal, Kate E Templeton, Joshua Matovu, Christine Sekaggya‐Wiltshire, James W. Dear · 2021 · British Journal of Clinical Pharmacology
67. End-point definition and trial design to advance tuberculosis vaccine development
    Alberto L. García‐Basteiro, Richard Guy White, Dereck R. Tait, Alexander C. Schmidt, Molebogeng Xheedha Rangaka, Matthew Quaife, Elisa Nemes, Robin Mogg, Philip C. Hill, Rebecca Claire Harris et al. · 2022 · European Respiratory Review
68. Cerebral vasculitis and encephalitis due to Epstein–Barr virus in a patient with newly diagnosed HIV infection
    Lavanya Raman, Mark Richard Nelson · 2014 · Journal of Clinical Virology
69. Initiating antiretrovirals during tuberculosis treatment: a drug safety review
    Tanuja Narayansamy Gengiah, Andrew L Gray, Kogieleum Naidoo, Quarraisha Abdool Karim · 2011 · Expert Opinion on Drug Safety
70. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus‐infected persons
    Shui Shan Lee, Graeme Meintjes, Adeeba Kamarulzaman, Chi Chiu Leung · 2013 · Respirology
71. Main causes of death in Dande, Angola: results from Verbal Autopsies of deaths occurring during 2009–2012
    Edite Rosário, Diogo Costa, Luís Timóteo, Ana Ambrósio Rodrigues, Jorge Varanda, Susana Vaz Nery, Miguel Brito · 2016 · BMC Public Health
72. Malnutrition in HIV/AIDS: Aetiopathogenesis
    Vangal Krishnaswamy Sashindran, Rajneesh Thakur · 2020 · IntechOpen eBooks
73. Spectrum of AIDS Defining Opportunistic Infections in a Series of 77 Hospitalised HIV-Infected Omani Patients
    Abdullah Balkhair, Zakariya Al Muharrmi, Shyam S Ganguly, Ali Abdullah Al-Jabri · 2012 · Sultan Qaboos University medical journal
74. Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Shipeng Yan, Lizhang Chen, Wenqiong Wu, Zhongxi Fu, Heng Zhang, Zhanzhan Li, Chenchao Fu, Jinjin MOU, Jing Xue, Yingyun Hu · 2015 · PLoS ONE
75. Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia
    Tadesse, Sebsibe, Tadesse, Takele · 2014 · Health
76. Multiobjective optimization to a TB-HIV/AIDS coinfection optimal control problem
    Roman Denysiuk, Cristiana J. Silva, Delfim F. M. Torres · 2017 · Computational and Applied Mathematics
77. Double trouble?
    Lukas Engelmann, Janina Kehr · 2015 · Medicine Anthropology Theory
78. Identification of a Novel Serum Biomarker for Tuberculosis Infection in Chinese HIV Patients by iTRAQ-Based Quantitative Proteomics
    Cong Chen, Tao Yan, Liguo Liu, Jianmin Wang, Qi Jin · 2018 · Frontiers in Microbiology
79. The potential of plant systems to break the HIV‐TB link
    Peyman Habibi, Henry Daniell, Carlos Ricardo Soccol, Maria Fátima Grossi‐de‐Sá · 2019 · Plant Biotechnology Journal
80. HIV Protease Inhibitor–Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation
    Georgio Kourjian, Marijana Ručević, Matthew J. Berberich, Jens Dinter, Daniel Wambua, Julie Boucau, Sylvie Le Gall · 2016 · The Journal of Immunology
81. HLA-E–restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Coinfection
    Marco Pio La Manna, Valentina Orlando, Teresa Prezzemolo, Paola Di Carlo, Antonio Cascio, Giovanni Delogu, Guido Poli, Lucy Catherine Sullivan, Andrëw G. Brööks, Francesco Dieli et al. · 2019 · American Journal of Respiratory Cell and Molecular Biology
82. Synthesis and antitubercular activity of 1,2,4-trisubstitued piperazines
    Kyle H. Rohde, Heather A. Michaels, Adel Nefzi · 2016 · Bioorganic & Medicinal Chemistry Letters
83. Tuberculosis and HIV Co-infection, California, USA, 1993–2008
    John Z. Metcalfe, Travis C. Porco, Janice L. Westenhouse, Mark A. Damesyn, Matt Facer, Julia Hill, Qiang Xia, James Watt, Philip C. Hopewell, Jennifer Flood · 2012 · Emerging infectious diseases
84. Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis
    Keita Takeda, Hideaki Nagai, Maho Suzukawa, Ryo Sekiguchi, Shunsuke Akashi, Ryota Sato, Osamu Narumoto, Masahiro Kawashima, Junko Suzuki, Nobuharu Ohshima et al. · 2020 · Journal of Infection and Chemotherapy
85. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017
    Habtamu Belew, Moges Wubie, Getaye Tizazu, Abebaw Bitew, Tesfa Birlew · 2020 · BMC Infectious Diseases
86. PEPFAR Support for the Scaling Up of Collaborative TB/HIV Activities
    Andrea A. Howard, Michel Gasana, Haileyesus Getahun, Anthony David Harries, Stephen D Lawn, Bess Miller, Lisa J Nelson, Joseph K. Sitienei, William L. Coggin · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
87. HIV co-infection among tuberculosis patients in Dabat, northwest Ethiopia
    Sebsibe Tadesse · 2013 · Journal of Infectious Diseases and Immunity
88. Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania
    A. Gupta, Jessie Mbwambo, Ibrahim Mteza, Sheela Shenoi, Barrot H. Lambdin, Cassian Nyandindi, B I Doula, Saidi Mwinjuma Mfaume, Robert Douglas Bruce · 2014 · The International Journal of Tuberculosis and Lung Disease
89. The association between HIV infection and pulmonary function in a rural African population
    Meri R.J. Varkila, Alinda G. Vos, Roos E. Barth, Hugo A. Tempelman, W.L.J.M. Devillé, Roel A. Coutinho, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch · 2019 · PLoS ONE
90. Relationship between chemokine receptor expression, chemokine levels and HIV ‐1 replication in the lungs of persons exposed to M ycobacterium tuberculosis
    Barbara Kalsdorf, Keira H. Skolimowska, Thomas J. Scriba, Rod Dawson, Keertan U.J. Dheda, Kathryn J. Wood, Jessica Hofmeister, Willem Albert Hanekom, Christoph G. Lange, Robert John Wilkinson · 2012 · European Journal of Immunology
91. Human Immunodeficiency Virus and Uveitis
    Mingming Yang, Koju Kamoi, Yuan Zong, Jing Zhang, Kyoko Ohno‐Matsui · 2023 · Viruses
92. Advancing personalized medicine for tuberculosis through the application of immune profiling
    Vo Thuy Anh Thu, Dat Da Ly, Rannissa Puspita Jayanti, Hoang Kim Tu Trinh, Tran Minh Hung, Yong‐Soon Cho, Nguyen Phuoc Long, Jae‐Gook Shin · 2023 · Frontiers in Cellular and Infection Microbiology
93. EXTRAPULMONARY TUBERCULOSIS IN HIV PATIENTS
    Mikhail Valerevich Sinitsyn, Evgeny M. Belilovsky, Irina Sokolina, Mikhail Nikolaevich Reshetnikov, Titiukhina Mv, О В Батурин · 2017 · Tuberculosis and lung diseases
94. Rifampicin Resistant Tuberculosis in a Secondary Health Institution in Nigeria, West Africa
    Rasaki O. Shittu · 2014 · Journal of Infectious Diseases and Therapy
95. Statistical Analysis on Determinant Factors Associated with Time to Death of HIV/TB Co-Infected Patients Under HAART at Debre Tabor Referral Hospital: An Application of Accelerated Failure Time-Shared Frailty Models
    Hailegebrael Birhan Biresaw, Kenaw Derebe Fentaw, Setegn Muche Fenta, Bezanesh Melese Masresha · 2021 · HIV/AIDS - Research and Palliative Care
96. Converging Epidemics: A Narrative Review of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Coinfection
    Asmi Bhatt, Quazi Syed Zahiruddin, Harshit Singh · 2023 · Cureus
97. Functional assignment of Mycobacterium tuberculosis proteome revealed by genome-scale fold-recognition
    Chunhong Mao, Maulik P. Shukla, Gerald J Larrouy-Maumus, Flora Lucy Dix, Lawrence A. Kelley, Michael J.E. Sternberg, Bruno Sobral, Luiz Pedro S. de Carvalho · 2013 · Tuberculosis
98. Validation of Biomarkers for Distinguishing Mycobacterium tuberculosis from Non-Tuberculous Mycobacteria Using Gas Chromatography−Mass Spectrometry and Chemometrics
    Ngoc A. Dang, Sjoukje Kuijper, Elisabetta Ghimenton Walters, Mareli Misha Claassens, Dick van Soolingen, Gabriel Vivó‐Truyols, Hans‐Gerd Janssen, Arend H. J. Kolk · 2013 · PLoS ONE
99. Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis
    Gizaw Eshetu Abaye, Tamrat Abebe, Adane Worku, Debela Tolessa, Gobena Ameni, Adane Mihret · 2017 · PLoS ONE
100. Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study
     Nishta Kaushik, Christopher Lowbridge, Gabriella M. Scandurra, Claudia Caroline Dobler · 2018 · ERJ Open Research